Pure Biologics S.A. (FRA:PQB)

Market Cap	8.25M
Revenue (ttm)	n/a
Net Income (ttm)	-4.20M
Shares Out	n/a
EPS (ttm)	-1.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	0.9245
Previous Close	0.9360
Day's Range	0.9245 - 0.9245
52-Week Range	0.6055 - 3.9250
Beta	n/a
RSI	50.63
Earnings Date	Apr 29, 2026

About Pure Biologics

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified apta...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PQB

Financial Performance

Financial numbers in PLN